Article Dans Une Revue European Journal of Human Genetics Année : 2024

A Phase II double-blind multi-center, placebocontrolled trial, to assess the efficacy and safety of alpelisib (BYL719) in pediatric and adult patients with Megalencephaly-CApillary malformation Polymicrogyria syndrome (MCAP): the SESAM trial

Laurent Guibaud
  • Fonction : Auteur
  • PersonId : 940989
Estelle Colin
  • Fonction : Auteur
  • PersonId : 906473
Olivia Boccara
Amélie Cransac-Miet
Fichier non déposé

Dates et versions

hal-04554937 , version 1 (22-04-2024)

Identifiants

  • HAL Id : hal-04554937 , version 1

Citer

Maxime Luu, Agnes Maurer, Guillaume Canaud, Adelaïde Rega, Laurent Guibaud, et al.. A Phase II double-blind multi-center, placebocontrolled trial, to assess the efficacy and safety of alpelisib (BYL719) in pediatric and adult patients with Megalencephaly-CApillary malformation Polymicrogyria syndrome (MCAP): the SESAM trial. European Journal of Human Genetics, 2024, 32 (Supplement 1), pp.331-332 - Meeting Abstract EP22.006. ⟨hal-04554937⟩
146 Consultations
0 Téléchargements

Partager

  • More